A new CSP position was established today on Novartis (NVS). All prices include IB commissions.
| Criteria | Value |
|---|
| Dividend Champions Status | Contender |
| Years of Consecutive Dividend Increases | 10 |
| Fair Value Estimate | $71.00 |
| Target Buy Price | $56.80 |
| Target Margin of Safety | 20.00% |
| Actual Buy Price | $55.00 |
| Actual Margin of Safety | 22.54% |
| Date | Stock | Description | Transaction | Status | Stock Investment | Income Generated |
|---|
| 10/31/2011 | NVS | CSP Margin Used | CSP 100 NVS @ 55.00 | | ($5,500.00) | |
| 10/31/2011 | NVS | Initial Put Option | STO 1 Dec11 55.00 Put @ 1.29 | | | $128.98 |
Position Summary
| Cost Basis | ($5,500.00) |
| Income Generated | $128.98 |
| Percent Income Generated | 2.35% |
| Annualized Income Generated | 18.61% |
| Net Profit If Assigned | $128.98 |
| Percent Return If Assigned | 2.35% |
| Annualized Return If Assigned | 18.61% |
| Days Held to Expiration | 46 days |
